These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 11239913
41. delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain. Burkey TH, Quock RM, Consroe P, Roeske WR, Yamamura HI. Eur J Pharmacol; 1997 Apr 04; 323(2-3):R3-4. PubMed ID: 9128853 [Abstract] [Full Text] [Related]
42. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain. Erdozain AM, Diez-Alarcia R, Meana JJ, Callado LF. Biochem Pharmacol; 2012 Jan 15; 83(2):260-8. PubMed ID: 22093909 [Abstract] [Full Text] [Related]
44. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodríguez de Fonseca F. J Neurosci; 2002 Nov 01; 22(21):9612-7. PubMed ID: 12417686 [Abstract] [Full Text] [Related]
45. Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2. Aceto MD, Scates SM, Martin BB. Eur J Pharmacol; 2001 Mar 23; 416(1-2):75-81. PubMed ID: 11282115 [Abstract] [Full Text] [Related]
48. N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor. Hurst DP, Lynch DL, Barnett-Norris J, Hyatt SM, Seltzman HH, Zhong M, Song ZH, Nie J, Lewis D, Reggio PH. Mol Pharmacol; 2002 Dec 23; 62(6):1274-87. PubMed ID: 12435794 [Abstract] [Full Text] [Related]
49. AM630 is an inverse agonist at the human cannabinoid CB1 receptor. Landsman RS, Makriyannis A, Deng H, Consroe P, Roeske WR, Yamamura HI. Life Sci; 1998 Dec 23; 62(9):PL109-13. PubMed ID: 9496703 [Abstract] [Full Text] [Related]
54. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes. Odagaki Y, Toyoshima R. Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb 23; 372(5):335-45. PubMed ID: 16491386 [Abstract] [Full Text] [Related]
55. Reciprocal inhibition of G-protein signaling is induced by CB(1) cannabinoid and GABA(B) receptor interactions in rat hippocampal membranes. Cinar R, Freund TF, Katona I, Mackie K, Szucs M. Neurochem Int; 2008 Jun 23; 52(8):1402-9. PubMed ID: 18407377 [Abstract] [Full Text] [Related]
56. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D. FEBS Lett; 1994 Aug 22; 350(2-3):240-4. PubMed ID: 8070571 [Abstract] [Full Text] [Related]
57. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. Hoffman AF, Oz M, Caulder T, Lupica CR. J Neurosci; 2003 Jun 15; 23(12):4815-20. PubMed ID: 12832502 [Abstract] [Full Text] [Related]
59. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice. McMahon LR, Koek W. Eur J Pharmacol; 2007 Aug 13; 569(1-2):70-6. PubMed ID: 17553486 [Abstract] [Full Text] [Related]
60. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R. Eur J Pharmacol; 2003 Feb 07; 461(1):27-34. PubMed ID: 12568912 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]